Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    9704731 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas
Conditions: Lymphoma, Large-Cell, Ki-1;   Lymphoma, T-Cell
Intervention: Drug: UCN-01 (7-hydroxystaurosporine)
2 Recruiting BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
Condition: Follicular Lymphoma
Intervention: Drug: BeEAM
3 Active, not recruiting Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: Dasatinib
4 Recruiting T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
Condition: Lymphoma, T-Cell, Peripheral
Intervention:

Indicates status has not been verified in more than two years